Relapse risk and predictors for relapse in a real-life cohort of IBD patients after discontinuation of anti-TNF therapy

被引：0
|
作者：
Bots, S. [1 ]
Kuin, S. [1 ]
Ponsioen, C. [1 ]
van den Brink, G. [1 ]
Lowenberg, M. [1 ]
D'Haens, G. [1 ]
机构：
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P611
引用
下载
收藏
页码：S391 / S391
页数：1
相关论文
共 50 条
  • [31] Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdraw: Reply
    Feld, Jordan J.
    King, Wendy C.
    Lok, Anna S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1969 - 1970
  • [32] Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patients
    Kato, S.
    Kani, K.
    Ishibashi, A.
    Oka, M.
    Nagoshi, S.
    Yakabi, K.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S298 - S298
  • [33] Risk of Relapse After Azathioprine (AZA) Discontinuation in Inflammatory Bowel Disease (IBD) Patients in Maintained Remission
    Iborra, Marisa
    Herreras, Julia
    Bosca-Watts, Marta M.
    Cortes, Xavier
    Navarro, Belen
    Martinez, Maria Teresa Blazquez
    Trejo, Galo A.
    Beltran, Belen
    Nos, Pilar
    GASTROENTEROLOGY, 2016, 150 (04) : S442 - S442
  • [34] Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
    Manson, G.
    Brice, P.
    Herbaux, C.
    Silva, M. G.
    Bouabdallah, K.
    Deau, B.
    Bouteloup, J.
    Schiano, J. M.
    Nicolas-Virelizier, E.
    Maerevoet, M.
    Ghesquieres, H.
    Stamatoullas, A.
    Antier, C.
    Carlo-Stella, C.
    de Charette, M.
    Poizeau, F.
    Dercle, L.
    Houot, Roch
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1144 - 1153
  • [35] Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
    G. Manson
    P. Brice
    C. Herbaux
    M. G. Silva
    K. Bouabdallah
    B. Deau
    J. Bouteloup
    J. M. Schiano
    E. Nicolas-Virelizier
    M. Maerevoet
    H. Ghesquieres
    A. Stamatoullas
    C. Antier
    C. Carlo-Stella
    M. de Charette
    F. Poizeau
    L. Dercle
    Roch Houot
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1144 - 1153
  • [36] To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn's Disease
    Christopher, M. A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1668 - 1670
  • [37] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [38] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Kumar, Manoj
    Murugesan, Selvasankar
    Ibrahim, Nazira
    Elawad, Mamoun
    Al Khodor, Souhaila
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [39] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Manoj Kumar
    Selvasankar Murugesan
    Nazira Ibrahim
    Mamoun Elawad
    Souhaila Al Khodor
    Journal of Translational Medicine, 22
  • [40] UVEITIS AS PREDICTORS OF RELAPSE AFTER ANTI-TNF TREATMENT WITHDRAWAL IN JUVENILE IDIOPATHIC ARTHRITIS: AN ITALIAN MULTICENTRIC EXPERIENCE
    Maccora, I.
    Trevisan, M.
    Accardo, V.
    Pagnini, I.
    La Torre, F.
    Marrani, E.
    Cattalini, M.
    Mastrolia, M. V.
    Taddio, A.
    Simonini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 670 - 670
12345